Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

264 public trials 97 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Recruiting

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

NCT06744920

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Fullerton Neuro and Headache Ctr Fullerton, California, United States
  • University Of Southern California Los Angeles, California, United States
View all 129 locations
View Trial Details
Recruiting

A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

NCT07595653

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +12 more
Locations
  • Ospedale Generale Regionale F. Miulli Acquaviva delle Fonti, Italy
  • Azienda Ospedaliero Universitaria delle Marche Ancona, Italy
  • A.O.U. Consorziale Policlinico Bari, Italy
  • ASST Papa Giovanni XXIII Bergamo, Italy
View all 30 locations
View Trial Details
Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +44 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Melbourne, Victoria, Australia
  • Research Site Paris, France
  • Research Site Essen, Norte-Westfalia, Germany
View Trial Details
Recruiting

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

NCT07221838

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Autoimmune Diseases, +15 more
Locations
  • Research Site Chicago, Illinois, United States
  • Research Site Schaumburg, Illinois, United States
  • Research Site Neptune City, New Jersey, United States
  • Research Site Raleigh, North Carolina, United States
View Trial Details

Related conditions